CLINICAL_TRIALS
trial_result
· 2019-08-13
Clinical Trial Update: Reevaluation Of Systemic Early Neuromuscular Blockade [Phase 3]
Summary
Phase 3 trial evaluating systemic early neuromuscular blockade in acute respiratory distress syndrome has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Acute Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-08-13